Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Clinical trial NCT06736041 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06736041
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2027-05-17
- Enrollment
- 1714
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.